FI925756A - Foerfarande foer rening av hyaluronsyra samt en ren hyaluronsyrafraktionavsedd foer oftalmisk anvaendning - Google Patents

Foerfarande foer rening av hyaluronsyra samt en ren hyaluronsyrafraktionavsedd foer oftalmisk anvaendning Download PDF

Info

Publication number
FI925756A
FI925756A FI925756A FI925756A FI925756A FI 925756 A FI925756 A FI 925756A FI 925756 A FI925756 A FI 925756A FI 925756 A FI925756 A FI 925756A FI 925756 A FI925756 A FI 925756A
Authority
FI
Finland
Prior art keywords
foer
oftalmisk
hyaluronsyrafraktionavsedd
hyaluronsyra
anvaendning
Prior art date
Application number
FI925756A
Other languages
English (en)
Other versions
FI925756A0 (fi
FI104973B (fi
Inventor
Aurelio Romeo
Silvana Lorenzi
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11389548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI925756(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of FI925756A0 publication Critical patent/FI925756A0/fi
Publication of FI925756A publication Critical patent/FI925756A/fi
Application granted granted Critical
Publication of FI104973B publication Critical patent/FI104973B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
FI925756A 1991-04-19 1992-12-18 Menetelmä hyaluronihapon puhdistamiseksi FI104973B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITPD910077A IT1247175B (it) 1991-04-19 1991-04-19 Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
ITPD910077 1991-04-19
PCT/EP1992/000861 WO1992018543A1 (en) 1991-04-19 1992-04-16 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
EP9200861 1992-04-16

Publications (3)

Publication Number Publication Date
FI925756A0 FI925756A0 (fi) 1992-12-18
FI925756A true FI925756A (fi) 1992-12-18
FI104973B FI104973B (fi) 2000-05-15

Family

ID=11389548

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925756A FI104973B (fi) 1991-04-19 1992-12-18 Menetelmä hyaluronihapon puhdistamiseksi

Country Status (24)

Country Link
US (1) US5559104A (fi)
EP (1) EP0535200B1 (fi)
JP (1) JP2580458B2 (fi)
KR (1) KR0178544B1 (fi)
AT (1) ATE186307T1 (fi)
AU (1) AU653022B2 (fi)
BR (1) BR9205240A (fi)
CA (1) CA2084875C (fi)
CZ (1) CZ282248B6 (fi)
DE (1) DE69230242T2 (fi)
DK (1) DK0535200T3 (fi)
ES (1) ES2092971T3 (fi)
FI (1) FI104973B (fi)
GR (1) GR3032434T3 (fi)
HU (1) HU215193B (fi)
IL (2) IL101611A (fi)
IT (1) IT1247175B (fi)
NO (1) NO305520B1 (fi)
PL (1) PL168477B1 (fi)
RU (1) RU2128666C1 (fi)
SG (1) SG46515A1 (fi)
SK (1) SK280191B6 (fi)
UA (1) UA27229C2 (fi)
WO (1) WO1992018543A1 (fi)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274984B (it) * 1994-12-09 1997-07-29 Technopharma Sa Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri
IT1282219B1 (it) * 1995-12-20 1998-03-16 Fidia Advanced Biopolymers Srl Processo chimico fisico combinato per la preparazione di frazioni di acido ialuronico a basso peso molecolare caratterizzate da bassa
IT1287967B1 (it) 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S Preparazioni farmaceutiche per uso anestetico locale
IT1291452B1 (it) 1997-04-14 1999-01-11 Fidia Advanced Biopolymers Srl Rivestimento a base di acido ialuronico e suoi derivati per la protezione di parti elettroniche da agenti esterni
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
EP1091936B1 (en) 1998-05-29 2003-07-30 Bone Care International, Inc. Method for making hydroxy-25-ene-vitamin d compounds
DK172900B1 (da) 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
IT1306644B1 (it) 1999-04-08 2001-10-02 Fidia Advanced Biopolymers Srl Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico.
KR100836733B1 (ko) * 2002-11-15 2008-06-10 코오롱생명과학 주식회사 히알우론산 나트륨의 회수방법 및 그를 위한 장치
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
KR100577075B1 (ko) * 2004-06-16 2006-05-08 주식회사 티앤라이프시스템 칼슘염 및 인산염, 또는 인산칼슘염을 이용한 히아루론산정제방법
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US8021684B2 (en) * 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
DE102005030011A1 (de) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
ITPD20050242A1 (it) 2005-08-03 2007-02-04 Fidia Farmaceutici Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
KR101509139B1 (ko) * 2006-11-23 2015-04-08 주식회사 엘지생명과학 히알루론산의 정제방법
KR100894042B1 (ko) * 2007-04-13 2009-04-20 가톨릭대학교 산학협력단 설파살라진-히알루론산 혼합물의 제조방법 및 이로부터얻어진 혼합물을 포함하는 후발성 백내장 억제용 조성물
US9089592B2 (en) 2007-04-26 2015-07-28 Seikagaku Corporation Method for micro-incision cataract surgery, a method of evaluation of a viscoelastic material, a composition for evaluation of a viscoelastic material and a method for evaluation using the composition
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
KR20100094982A (ko) * 2007-11-13 2010-08-27 바이오-테크널러지 제너럴 (이스라엘) 리미티드 점탄성 바이오폴리머의 희석식 여과 멸균 방법
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
WO2009124266A2 (en) 2008-04-04 2009-10-08 University Of Utah Research Foundation Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
WO2012118192A1 (ja) * 2011-03-02 2012-09-07 電気化学工業株式会社 ヒアルロン酸またはその塩を含む水溶液
KR20140024862A (ko) * 2011-03-02 2014-03-03 덴키 가가쿠 고교 가부시기가이샤 히알루론산 또는 히알루론산염을 포함하는 수용액
CN103547273A (zh) * 2011-03-02 2014-01-29 电气化学工业株式会社 一种向具有树脂制筒部的注射器内注入含透明质酸或透明质酸盐的水溶液而成的预充式注射器
WO2012118193A1 (ja) * 2011-03-02 2012-09-07 電気化学工業株式会社 ヒアルロン酸またはその塩を含む水溶液
KR20140024863A (ko) * 2011-03-02 2014-03-03 덴키 가가쿠 고교 가부시기가이샤 히알루론산 또는 히알루론산염을 포함하는 수용액
EP2688402B1 (en) 2011-03-23 2018-10-24 University of Utah Research Foundation Means for treating or preventing urological inflammation
RU2477138C1 (ru) * 2011-11-02 2013-03-10 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения заполняющего материала для пластической хирургии и инструментальной косметологии, заполняющий материал и способ введения заполняющего материала в проблемную зону
ITMI20120664A1 (it) 2012-04-20 2013-10-21 Anika Therapeutics Srl Biomateriali a base di gellano per l'uso come filler in chirurgia
US10723812B2 (en) 2014-02-06 2020-07-28 New York University Method for separating hyaluronan and quantifying its molecular mass distribution in biological samples
IT201600079633A1 (it) * 2016-07-28 2018-01-28 Fidia Farm Spa Procedimento di preparazione e purificazione del sale sodico dell’acido ialuronico
WO2018053111A1 (en) 2016-09-15 2018-03-22 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
AU2020395914A1 (en) 2019-12-05 2022-05-19 Cis Pharma Ag High hyaluronate multi-purpose disinfection solutions for ophthalmic applications
RU2765951C1 (ru) * 2021-05-14 2022-02-07 Общество с ограниченной ответственностью "АВЕО" Способ очистки гиалуроната от эндотоксинов

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4766348A (en) * 1983-06-09 1988-08-23 Gte Products Corporation Single-ended metal halogen lamp and fabrication process employing ionization potential selection of additive gases
LU85582A1 (fr) * 1983-10-11 1985-06-04 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique,procedes pour leur preparation et compositions pharmaceutiques les contenant
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
JPS6121241A (ja) * 1984-07-10 1986-01-29 オリエンタル建設株式会社 プレストレストコンクリ−ト部材組立式ラ−メン構造体における多スパン梁の構築方法
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
AU600257B2 (en) * 1986-03-21 1990-08-09 International Pharmaceutical Products, Inc. Non-inflammatory hyaluronic acid fraction and process for preparing it
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
JPH0813847B2 (ja) * 1987-08-11 1996-02-14 日本化薬株式会社 ヒアルロン酸の分画法
JPH01210401A (ja) * 1988-02-17 1989-08-24 Mitsubishi Rayon Co Ltd 酸性多糖類の分離法
JPH0723317B2 (ja) * 1988-03-17 1995-03-15 生化学工業株式会社 角膜上皮層障害症治療剤
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
JP2731545B2 (ja) * 1988-10-12 1998-03-25 電気化学工業株式会社 ヒアルロン酸の精製方法

Also Published As

Publication number Publication date
ES2092971T1 (es) 1996-12-16
SK280191B6 (sk) 1999-09-10
DE69230242T2 (de) 2000-06-21
IT1247175B (it) 1994-12-12
DE69230242D1 (de) 1999-12-09
FI925756A0 (fi) 1992-12-18
AU1576692A (en) 1992-11-17
IL113453A (en) 1995-07-31
HU215193B (hu) 1998-10-28
EP0535200A1 (en) 1993-04-07
ITPD910077A1 (it) 1992-10-19
HU9204012D0 (en) 1993-03-29
ES2092971T3 (es) 2000-01-01
CA2084875C (en) 1998-01-06
KR930700557A (ko) 1993-03-15
IL113453A0 (en) 1995-07-31
NO924873D0 (no) 1992-12-16
FI104973B (fi) 2000-05-15
AU653022B2 (en) 1994-09-15
HUT63186A (en) 1993-07-28
JP2580458B2 (ja) 1997-02-12
WO1992018543A1 (en) 1992-10-29
PL297297A1 (en) 1993-09-06
NO924873L (no) 1993-02-19
CZ282248B6 (cs) 1997-06-11
ITPD910077A0 (it) 1991-04-19
EP0535200B1 (en) 1999-11-03
RU2128666C1 (ru) 1999-04-10
PL168477B1 (pl) 1996-02-29
US5559104A (en) 1996-09-24
KR0178544B1 (ko) 1999-04-01
NO305520B1 (no) 1999-06-14
ATE186307T1 (de) 1999-11-15
DK0535200T3 (da) 2000-05-08
SK377192A3 (en) 1995-06-07
BR9205240A (pt) 1993-08-31
UA27229C2 (uk) 2000-08-15
CZ377192A3 (en) 1993-05-12
GR3032434T3 (en) 2000-05-31
JPH05508183A (ja) 1993-11-18
SG46515A1 (en) 1998-02-20
IL101611A (en) 1996-06-18
CA2084875A1 (en) 1992-10-20

Similar Documents

Publication Publication Date Title
FI925756A (fi) Foerfarande foer rening av hyaluronsyra samt en ren hyaluronsyrafraktionavsedd foer oftalmisk anvaendning
AU6088994A (en) Process for producing sodium salts from brines of sodium ores
RU92016520A (ru) Фракция гиалуроновой кислоты или ее соли для применения в офтальмологии, способ получения гиалуроновой кислоты и ее соли, фармацевтический препарат
AU1331588A (en) Method for treatment of alcohol abuse
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
AU6143794A (en) Use of riluzole for treating aids-related neural disorders
SE8505136D0 (sv) Anordning for data for formen pa glasogonbagar
DE69526369T2 (de) Entzündungshemmende augentropfen
EP0288907A3 (en) Method for inhibiting loss of cognitive functions employing an ace inhibitor
AU2829395A (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
HU9204171D0 (en) Method for producing aralkyl esters of 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracene-carboxylic acid as well as medical preparatives containing them
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
WO1990003172A3 (en) Bile acids for treatment of viral infections
AU6129096A (en) Use of pyrrolidine derivatives in the treatment of alcoholism
AU7625096A (en) Production of a salt of clavulanic acid
TW347383B (en) A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use
EP0387677A3 (en) Thienylacetic acid derivatives, process for their preparation, their application as well as pharmaceuticals containing them and their preparation
AU7130396A (en) Process for the continuous production of basic cyclic optically active alpha-amino acids
ES8303405A1 (es) Procedimiento de preparacion de derivados de quinidina.
ATE79756T1 (de) Arzneimittel zur behandlung von augenentzuendung.
GR960100116A (el) Μεθοδος παρασκευης 1-κυκλοπροπυλο-6-φλουορο-1,4-διυδρο-7-[(1s,4s)-5-μεθυλο-2,5-διαζαβικυκλο[2.2.1]-επτ-2-υλο] -4-οξο-3-κουινολινοκαρβοξυλικο οξυ και αλατα αυτων.
AU8142794A (en) Use of substituted 1,4-dihydropyridine to reduce intraocular pressure

Legal Events

Date Code Title Description
MA Patent expired